1
|
Wen J, Ping H, Kong X, Chai W. Developmental dysplasia of the hip: A systematic review of susceptibility genes and epigenetics. Gene 2023; 853:147067. [PMID: 36435507 DOI: 10.1016/j.gene.2022.147067] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Revised: 10/29/2022] [Accepted: 11/18/2022] [Indexed: 11/24/2022]
Abstract
BACKGROUND Developmental dysplasia of the hip (DDH) is a complex developmental deformity whose pathogenesis and susceptibility-related genes have yet to be elucidated. This systematic review summarizes the current literature on DDH-related gene mutations, animal model experiments, and epigenetic changes in DDH. METHODS We performed a comprehensive search of relevant documents in the Medline, Scopus, Cochrane, and ScienceDirect databases covering the period from October 1991 to October 2021. We analyzed basic information on the included studies and summarized the DDH-related mutation sites, animal model experiments, and epigenetic changes associated with DDH. RESULTS A total of 63 studies were included in the analysis, of which 54 dealt with the detection of gene mutations, 7 presented details of animal experiments, and 6 were epigenetic studies. No genetic mutations were clearly related to the pathogenesis of DDH, including the most frequently studied genes on chromosomes 1, 17, and 20. Most gene-related studies were performed in Han Chinese or North American populations, and the quality of these studies was medium or low. GDF5 was examined in the greatest number of studies, and mutation sites with odds ratios > 10 were located on chromosomes 3, 9, and 13. Six mutations were found in animal experiments (i.e., CX3CR1, GDF5, PAPPA2, TENM3, UFSP2, and WISP3). Epigenetics research on DDH has focused on GDF5 promoter methylation, three microRNAs (miRNAs), and long noncoding RNAs. In addition, there was also a genetic test for miRNA and mRNA sequencing. CONCLUSIONS DDH is a complex joint deformity with a considerable genetic component whose early diagnosis is significant for preventing disease. At present, no genes clearly involved in the pathogenesis of DDH have been identified. Research on mutations associated with this condition is progressing in the direction of in vivo experiments in animal models to identify DDH susceptibility genes and epigenetics analyses to provide novel insights into its pathogenesis. In the future, genetic profiling may improve matters.
Collapse
Affiliation(s)
- Jiaxin Wen
- School of Medicine, Nankai University, Tianjin, China
| | - Hangyu Ping
- School of Medicine, Nankai University, Tianjin, China
| | | | - Wei Chai
- School of Medicine, Nankai University, Tianjin, China.
| |
Collapse
|
2
|
Kenanidis E, Gkekas NK, Karasmani A, Anagnostis P, Christofilopoulos P, Tsiridis E. Genetic Predisposition to Developmental Dysplasia of the Hip. J Arthroplasty 2020; 35:291-300.e1. [PMID: 31522852 DOI: 10.1016/j.arth.2019.08.031] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2019] [Revised: 07/14/2019] [Accepted: 08/12/2019] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND The etiopathogenesis of developmental dysplasia of the hip (DDH) has not been clarified. This systematic review evaluated current literature concerning all known chromosomes, loci, genes, and their polymorphisms that have been associated or not with the prevalence and severity of DDH. METHODS Following the established methodology of Meta-analysis of Observational Studies in Epidemiology guidelines, MEDLINE, EMBASE, and Cochrane Register of Controlled Trials were systematically searched from inception to January 2019. RESULTS Forty-five studies were finally included. The majority of genetic studies were candidate gene association studies assessing Chinese populations with moderate methodological quality. Among the most frequently studied are the first, third, 12th,17th, and 20th chromosomes. No gene was firmly associated with DDH phenotype. Studies from different populations often report conflicting results on the same single-nucleotide polymorphism (SNP). The SNP rs143384 of GDF5 gene on chromosome 20 demonstrated the most robust relationship with DDH phenotype in association studies. The highest odds of coinheritance in linkage studies have been reported for regions of chromosome 3 and 13. Five SNPs have been associated with the severity of DDH. Animal model studies validating previous human findings provided suggestive evidence of an inducing role of mutations of the GDF5, CX3CR1, and TENM3 genes in DDH etiopathogenesis. CONCLUSION DDH is a complex disorder with environmental and genetic causes. However, no firm correlation between genotype and DDH phenotype currently exists. Systematic genome evaluation in studies with larger sample size, better methodological quality, and assessment of DDH patients is necessary to clarify the DDH heredity. The role of next-generation sequencing techniques is promising.
Collapse
Affiliation(s)
- Eustathios Kenanidis
- Centre of Orthopaedic and Regenerative Medicine (CORE), Center for Interdisciplinary Research and Innovation (CIRI)-Aristotle University of Thessaloniki (AUTH), Thessaloniki, Balkan Center, Greece; Academic Orthopaedic Department, Aristotle University Medical School, General Hospital Papageorgiou, Thessaloniki, Greece
| | - Nifon K Gkekas
- Centre of Orthopaedic and Regenerative Medicine (CORE), Center for Interdisciplinary Research and Innovation (CIRI)-Aristotle University of Thessaloniki (AUTH), Thessaloniki, Balkan Center, Greece; Academic Orthopaedic Department, Aristotle University Medical School, General Hospital Papageorgiou, Thessaloniki, Greece
| | - Areti Karasmani
- Centre of Orthopaedic and Regenerative Medicine (CORE), Center for Interdisciplinary Research and Innovation (CIRI)-Aristotle University of Thessaloniki (AUTH), Thessaloniki, Balkan Center, Greece
| | - Panagiotis Anagnostis
- Centre of Orthopaedic and Regenerative Medicine (CORE), Center for Interdisciplinary Research and Innovation (CIRI)-Aristotle University of Thessaloniki (AUTH), Thessaloniki, Balkan Center, Greece
| | | | - Eleftherios Tsiridis
- Centre of Orthopaedic and Regenerative Medicine (CORE), Center for Interdisciplinary Research and Innovation (CIRI)-Aristotle University of Thessaloniki (AUTH), Thessaloniki, Balkan Center, Greece; Academic Orthopaedic Department, Aristotle University Medical School, General Hospital Papageorgiou, Thessaloniki, Greece
| |
Collapse
|
3
|
Elhaji Y, Hedlin C, Nath A, Price EL, Gallant C, Northgrave S, Hull PR. AAGAB Mutations in 18 Canadian Families With Punctate Palmoplantar Keratoderma and a Possible Link to Cancer. J Cutan Med Surg 2019; 24:28-32. [PMID: 31526046 DOI: 10.1177/1203475419878161] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Punctate palmoplantar keratoderma type 1 (PPPK1) presents in late childhood to adulthood with multiple small discrete hyperkeratotic papules on palms and soles. PPPK1 is an autosomal dominant skin disease caused by AAGAB mutations. It has been suggested that PPPK1 may be associated with an increased predisposition to systemic malignancies. OBJECTIVES To evaluate the presence of AAGAB mutations in Canadian families with PPPK1 and the possible increased predisposition to systemic malignancies. METHODS Eighteen unrelated Canadian families with PPPK1 were recruited for this study. Genomic DNA was extracted from saliva and PCR amplification was performed for all AAGAB exons and exon/intron junctions. PCR products were sequenced and analyzed for mutations. A family history of malignancy was obtained from the index case and, when possible, from other family members. RESULTS We have identified 5 heterozygous AAGAB loss of function mutations in 11 families. The mutation c.370 C>T, p.Arg124* was the most prevalent and was identified in 6 families. A splice site mutation, c.451+3delAAGT, was identified in 2 families. The other mutations c.473delG, p.Gly158Glufs*0; c.550-551insAAT, p.Gly183*; and c.505-506 dupAA, p.Asn169Lysfs*6 were each identified in 1 family. Different cancers were reported in 11 families (Table 1 and Supplemental Figure S1). CONCLUSIONS AAGAB mutations were found in 11 of 18 families with PPPK1. In some families there appears to be an association with cancer.
Collapse
Affiliation(s)
- Youssef Elhaji
- 3688 Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada
| | - Cherise Hedlin
- 7235 Division of Dermatology, Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
| | - Anu Nath
- 3688 Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada
| | - Emma L Price
- 3688 Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada
| | - Christopher Gallant
- 3688 Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada
| | - Stacey Northgrave
- 3688 Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada
| | - Peter R Hull
- 3688 Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada
| |
Collapse
|
4
|
Zamiri M, Wilson N, Mackenzie A, Sobey G, Leitch C, Smith F. Painful punctate palmoplantar keratoderma due to heterozygous mutations in
AAGAB. Br J Dermatol 2019; 180:1250-1251. [DOI: 10.1111/bjd.17442] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- M. Zamiri
- Alan Lyell Centre for Dermatology Queen Elizabeth University Hospital Glasgow U.K
| | - N.J. Wilson
- Dermatology and Genetic Medicine Division of Biological Chemistry and Drug Discovery School of Life Sciences University of Dundee Dundee U.K
| | - A. Mackenzie
- Department of Dermatology Borders General Hospital Melrose U.K
| | - G. Sobey
- Department of Clinical Genetics Sheffield Children's Hospital Sheffield U.K
| | - C. Leitch
- Department of Dermatology Lauriston Building Edinburgh U.K
| | - F.J.D. Smith
- Dermatology and Genetic Medicine Division of Biological Chemistry and Drug Discovery School of Life Sciences University of Dundee Dundee U.K
- Pachyonycha Congenita Project Holladay UT U.S.A
| |
Collapse
|
5
|
Guerra L, Castori M, Didona B, Castiglia D, Zambruno G. Hereditary palmoplantar keratodermas. Part I. Non-syndromic palmoplantar keratodermas: classification, clinical and genetic features. J Eur Acad Dermatol Venereol 2018; 32:704-719. [PMID: 29489036 DOI: 10.1111/jdv.14902] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2017] [Accepted: 02/09/2018] [Indexed: 12/15/2022]
Abstract
The term palmoplantar keratoderma (PPK) indicates any form of persistent thickening of the epidermis of palms and soles and includes genetic as well as acquired conditions. We review the nosology of hereditary PPKs that comprise an increasing number of entities with different prognoses, and a multitude of associated cutaneous and extracutaneous features. On the basis of the phenotypic consequences of the underlying genetic defect, hereditary PPKs may be divided into the following: (i) non-syndromic, isolated PPKs, which are characterized by a unique or predominant palmoplantar involvement; (ii) non-syndromic PPKs with additional distinctive cutaneous and adnexal manifestations, here named complex PPKs; (iii) syndromic PPKs, in which PPK is associated with specific extracutaneous manifestations. To date, the diagnosis of the different hereditary PPKs is based mainly on clinical history and features combined with histopathological findings. In recent years, the exponentially increasing use of next-generation sequencing technologies has led to the identification of several novel disease genes, and thus substantially contributed to elucidate the molecular basis of such a heterogeneous group of disorders. Here, we focus on hereditary non-syndromic isolated and complex PPKs. Syndromic PPKs are reviewed in the second part of this 2-part article, where other well-defined genetic diseases, which may present PPK among their phenotypic manifestations, are also listed and diagnostic and therapeutic approaches for PPKs are summarized.
Collapse
Affiliation(s)
- L Guerra
- Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy
| | - M Castori
- Division of Medical Genetics, Casa Sollievo della Sofferenza-IRCCS, San Giovanni Rotondo, Foggia, Italy
| | - B Didona
- Rare Skin Disease Center, Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy
| | - D Castiglia
- Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy
| | - G Zambruno
- Genetic and Rare Diseases Research Area and Dermatology Unit, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy
| |
Collapse
|
6
|
Charfeddine C, Ktaifi C, Laroussi N, Hammami H, Jmel H, Landoulsi Z, Badri T, Benmously R, Bchetnia M, Boubaker M, Fenniche S, Abdelhak S, Mokni M. Clinical and molecular investigation of Buschke-Fischer-Brauer in consanguineous Tunisian families. J Eur Acad Dermatol Venereol 2016; 30:2122-2130. [DOI: 10.1111/jdv.13787] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2016] [Accepted: 04/11/2016] [Indexed: 01/03/2023]
Affiliation(s)
- C. Charfeddine
- Laboratory of Biomedical Genomics and Oncogenetics (LR11IPT05); University of Tunis El Manar; Pasteur Institut of Tunis; Tunis Tunisia
- High Institut of Biotechnology of Sidi Thabet; University of Manouba; Biotechpole of SidiThabet; Ariana Tunisia
| | - C. Ktaifi
- Laboratory of Biomedical Genomics and Oncogenetics (LR11IPT05); University of Tunis El Manar; Pasteur Institut of Tunis; Tunis Tunisia
| | - N. Laroussi
- Laboratory of Biomedical Genomics and Oncogenetics (LR11IPT05); University of Tunis El Manar; Pasteur Institut of Tunis; Tunis Tunisia
| | - H. Hammami
- Department of Dermatology; Habib Thameur Hospital; Tunis Tunisia
- Laboratory of Genodermatosis and Cancer (LR12SP03); University of Tunis El Manar; Faculty of Medecine Tunis; Tunis Tunisia
| | - H. Jmel
- Laboratory of Biomedical Genomics and Oncogenetics (LR11IPT05); University of Tunis El Manar; Pasteur Institut of Tunis; Tunis Tunisia
| | - Z. Landoulsi
- Laboratory of Biomedical Genomics and Oncogenetics (LR11IPT05); University of Tunis El Manar; Pasteur Institut of Tunis; Tunis Tunisia
| | - T. Badri
- Department of Dermatology; Habib Thameur Hospital; Tunis Tunisia
| | - R. Benmously
- Department of Dermatology; Habib Thameur Hospital; Tunis Tunisia
| | - M. Bchetnia
- Laboratory of Biomedical Genomics and Oncogenetics (LR11IPT05); University of Tunis El Manar; Pasteur Institut of Tunis; Tunis Tunisia
| | - M.S. Boubaker
- Department of Human and Experimental Pathology; Pasteur Institute of Tunis; Tunis Tunisia
| | - S. Fenniche
- Department of Dermatology; Habib Thameur Hospital; Tunis Tunisia
- Laboratory of Genodermatosis and Cancer (LR12SP03); University of Tunis El Manar; Faculty of Medecine Tunis; Tunis Tunisia
| | - S. Abdelhak
- Laboratory of Biomedical Genomics and Oncogenetics (LR11IPT05); University of Tunis El Manar; Pasteur Institut of Tunis; Tunis Tunisia
| | - M. Mokni
- Department of Dermatology; CHU La Rabta Tunis; Tunis Tunisia
- CHU La Rabta Tunis; Research Unit on Hereditary Keratinizaton Disorders UR12SP07; Tunis Tunisia
| |
Collapse
|
7
|
Akasaka E, Okawa Y, Nakano H, Takiyoshi N, Rokunohe D, Toyomaki Y, Sawamura D, Sueki H. Two Japanese familial cases of punctate palmoplantar keratoderma caused by a novel AAGAB mutation, c.191_194delCAAA. J Dermatol Sci 2015; 78:156-8. [PMID: 25771163 DOI: 10.1016/j.jdermsci.2015.02.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2014] [Revised: 01/16/2015] [Accepted: 02/06/2015] [Indexed: 12/23/2022]
Affiliation(s)
- Eijiro Akasaka
- Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - Yuko Okawa
- Division of Dermatology, Showa University Northern Yokohama Hospital, Yokohama, Japan
| | - Hajime Nakano
- Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
| | - Noriko Takiyoshi
- Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - Daiki Rokunohe
- Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - Yuka Toyomaki
- Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - Daisuke Sawamura
- Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - Hirohiko Sueki
- Department of Dermatology, Showa University Graduate School of Medicine, Tokyo, Japan
| |
Collapse
|
8
|
Pohler E, Huber M, Boonen SE, Zamiri M, Gregersen PA, Sommerlund M, Ramsing M, Hohl D, McLean WHI, Smith FJD. New and recurrent AAGAB mutations in punctate palmoplantar keratoderma. Br J Dermatol 2014; 171:433-6. [PMID: 24588319 PMCID: PMC4282079 DOI: 10.1111/bjd.12927] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- E Pohler
- Centre for Dermatology and Genetic Medicine, Colleges of Life Sciences and Medicine, Dentistry and Nursing, University of Dundee, Dundee, U.K
| | | | | | | | | | | | | | | | | | | |
Collapse
|